Tobam Abb Vie Inc. Transaction History

Tobam

$1.12 Billion
Q1 2024

A detailed history of Tobam transactions in Abb Vie Inc. stock. As of the latest transaction made, Tobam holds 175,361 shares of ABBV stock, worth $30.1 Million. This represents 2.86% of its overall portfolio holdings.

Number of Shares

175,361

Previous 218,747 19.83%

Holding current value

$30.1 Million

Previous $33.9 Million 5.8%

% of portfolio

2.86%

Previous 2.96%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 02, 2024	SELL	$159.82 - $182.1 $6.93 Million - $7.9 Million	-43,386 Reduced 19.83%	175,361 $31.9 Million
Q4 2023 Jan 26, 2024	SELL	$137.6 - $154.97 $3.7 Million - $4.17 Million	-26,904 Reduced 10.95%	218,747 $33.9 Million
Q3 2023 Oct 31, 2023	SELL	$133.59 - $154.65 $4.29 Million - $4.97 Million	-32,141 Reduced 11.57%	245,651 $36.6 Million
Q2 2023 Jul 31, 2023	BUY	$132.51 - $164.9 $7.55 Million - $9.4 Million	57,004 Added 25.82%	277,792 $37.4 Million
Q1 2023 May 03, 2023	BUY	$144.61 - $166.54 $7.21 Million - $8.31 Million	49,873 Added 29.18%	220,788 $35.2 Million

Q4 2022 Feb 02, 2023	BUY	$138.31 - $165.87 $6.98 Million - $8.37 Million	50,459 Added 41.89%	170,915 $27.6 Million
Q3 2022 Nov 02, 2022	BUY	$134.21 - $153.93 $9.68 Million - $11.1 Million	72,131 Added 149.26%	120,456 $16.2 Million
Q2 2022 Aug 02, 2022	BUY	$137.62 - $174.96 $5.46 Million - $6.94 Million	39,651 Added 457.12%	48,325 $7.4 Million
Q1 2022 Apr 25, 2022	BUY	$131.98 - $163.75 $378,518 - $469,635	2,868 Added 49.4%	8,674 $1.41 Million
Q2 2021 Aug 11, 2021	SELL	$105.21 - $117.21 $36,297 - $40,437	-345 Reduced 5.61%	5,806 $654,000
Q4 2020 Feb 03, 2021	BUY	$80.49 - $108.67 $8,129 - $10,975	101 Added 1.67%	6,151 $659,000
Q3 2020 Nov 12, 2020	BUY	$85.91 - $100.83 $519,755 - $610,021	6,050 New	6,050 $530,000

Others Institutions Holding ABBV

# of Institutions

3,651

Shares Held

1.24B

Call Options Held

15.5M

Put Options Held

11.6M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $303B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tobam, based on Form 13F filings with the SEC.

News

Stay updated on Tobam with notifications on news.

Account